Ocumension Therapeutics-B (01477.HK): Fluocinolone acetonide intravitreal implant approved by the National Medical Products Administration for production in mainland China

Zhitong Finance APP News, Ocumension Therapeutics-B (01477.HK) announced that the Group's fluocinolone acetonide intravitreal implant has recently been approved by the National Medical Products Administration of the People's Republic of China for production in mainland China.